This Fortnight in Medicine XXII

About this episode

This episode discusses various studies related to myocardial infarction and treatment strategies, including the risks associated with glucagon-like peptide-1 receptor agonists among veterans with type 2 diabetes.

* Glucagon-like peptide-1 receptor agonists and risk of substance use disorders among US veterans with type 2 diabetes: cohort study * Immediate or Deferred Nonculprit-Lesion PCI in Myocardial Infarction * Andrew’s previous SM post on the subject: How a Meta-Analysis can Mislead—The Story of Complete vs Culprit-only PCI in STEMI And, a bunch of the other studies we discussed. * Complete Revascularization with Multivessel PCI for Myocardial Infarction * FFR-Guided Complete or Culprit-Only PCI in Patients with Myocardial Infarction * Initial Invasive or Conservative Strategy for Stable Coronary Disease This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.sensible-med.com/subscribe

People in this episode

Host: Sensible Medicine Authors and Editors

Topics covered

• glucagon-like peptide-1 receptor agonists
• substance use disorders
• myocardial infarction
• complete revascularization
• PCI strategies
• coronary disease

Keywords

• glucagon-like peptide-1
• substance use disorders
• myocardial infarction
• PCI
• complete revascularization
• coronary disease
• FFR-guided PCI

Mentioned in this episode

Organizations: US veterans

Books & works: How a Meta-Analysis can Mislead—The Story of Complete vs Culprit-only PCI in STEMI

More episodes of Sensible Medicine

• This Fortnight in Medicine XXVII · June 3, 2026 · 33 min
• This Fortnight in Medicine XXVI · May 20, 2026 · 55 min
• This Fortnight in Medicine XXV · May 6, 2026 · 30 min
• This Fortnight in Medicine XXIV · April 22, 2026 · 46 min
• This Fortnight in Medicine XXIII · April 8, 2026 · 34 min
• This Fortnight in Medicine XXI · March 11, 2026 · 36 min